Agilent Synthesis of HIV-1 gp41 using AmphiSpheresTM Resin Application Note

Synthesis of HIV-1 gp41 using AmphiSpheresTM Resin


Agilent Synthesis of HIV-1 gp41 using AmphiSpheresTM Resin Application Note - cover page
Brand
Agilent
Category
Other
Document type
Application Note
Language
English
Pages
1
File format
PDF
File size
130 KB
Published
12 June, 2012
Updated
01 October, 2023
MD5 checksum
B07C5CE9A2296829C6DA61A24E117198

About this manual

This document details the synthesis of the 28-residue HIV-1 gp41 ectodomain sequence using Agilent AmphiSpheres 40 RAM resin. The peptide was prepared on a 0.1 mmol scale using a peptide synthesizer with Fmoc-AA-OH and HBTU coupling reagents. Following assembly and cleavage from the resin using TFA/TIPS/water, the peptide was purified and analyzed via HPLC and MS.

What's inside

  • Introduction
  • Instrumentation and Conditions
  • Sample Preparation
  • Response
  • Results and Discussion
  • Conclusions

Specifications

ColumnVarian Polaris 5 ym C18-A 150 x 4.6 mm
Gradient10 — 30% MeCN (0.1% TFA), 0 - 30 min
Flow rate1 mL/min
UV detector220 nm
Injection volume20 uL
Scale0.1 mmol

Frequently asked questions

What resin was used to synthesize HIV-1 gp41?

The synthesis was performed using AmphiSpheres 40 RAM resin.

How does AmphiSpheres resin compare to polyether resin?

AmphiSpheres resin outperformed commercially available polyether resin, as confirmed by HPLC/MS.

What is the molecular mass of the synthesized peptide?

The major peak was confirmed as 3653 [M+H]+.

Download PDF (130 KB)

More Agilent Manuals


View all Agilent manuals →